$0.8010
0.1218.12%
Last update: Nov 12, 7:33 AM
Cerenome Inc
CNSYNASDAQ
Cerenome fell 94.2% from $13.93 to $0.80, behind the S&P 500's +11.2%. Its worst day was Jan 14 (−38.2%), and its low came Nov 9 at $0.57.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Cerenome closed at its highest level of the year, 29.3% above where the year started.
+7.1% · S&P 500 +0.2%
Cerenome shares fell 38.2%, while the S&P 500 fell 0.5%.
−38.2%, the year's worst day · S&P 500 −0.5%
Story events cover the past 12 months · Times ET
EPS of $0.00 beat the $-0.75 estimate on $1.4M revenue (est. $1.8M).
−15.2% · S&P 500 −0.6%
Cerenome shares fell 24.2%, while the S&P 500 rose 2.9%.
−24.2% · S&P 500 +2.9%
Cerenome shares rose 23.7%, while the S&P 500 rose 0.6%.
+23.7%, the year's best day · S&P 500 +0.6%
EPS of $-1.05 missed the $-0.88 estimate on $1.0M revenue (est. $969,200.00).
+11.2% · S&P 500 −0.1%
EPS of $-1.31 missed the $-0.90 estimate on $411,000.00 revenue (est. $1.1M).
−13.0% · S&P 500 −0.5%
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Cerenome, Inc.
−31.4% · S&P 500 +1.7%
Where it ended: a close of $0.80 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-1.02, revenue est. $700,000.00).
Nothing in the past 12 months.
All CNSY dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CNSY and SPY from Benzinga historical bars. Not investment advice.
